Windsor Private Capital Lp Sells 33,500 Shares of Firefly Neuroscience (NASDAQ:AIFF) Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 33,500 shares of the stock in a transaction on Monday, October 20th. The stock was sold at an average price of $2.46, for a total value of $82,410.00. Following the transaction, the insider directly owned 1,334,026 shares in the company, valued at $3,281,703.96. The trade was a 2.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Wednesday, October 22nd, Windsor Private Capital Lp sold 78,031 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.07, for a total value of $161,524.17.
• On Tuesday, October 21st, Windsor Private Capital Lp sold 19,222 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.40, for a total value of $46,132.80.
• On Friday, October 17th, Windsor Private Capital Lp sold 45,036 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.55, for a total value of $114,841.80.
• On Thursday, October 16th, Windsor Private Capital Lp sold 40,139 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.65, for a total value of $106,368.35.
• On Wednesday, October 15th, Windsor Private Capital Lp sold 17,500 shares of Firefly Neuroscience stock. The stock was sold at an average price of $2.74, for a total value of $47,950.00.
• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total value of $80,830.00.
• On Monday, October 13th, Windsor Private Capital Lp sold 32,136 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.65, for a total value of $85,160.40.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.70, for a total value of $201,987.00.
• On Thursday, October 9th, Windsor Private Capital Lp sold 30,126 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.94, for a total value of $88,570.44.

Firefly Neuroscience Price Performance

Shares of AIFF stock opened at $2.05 on Friday. Firefly Neuroscience, Inc. has a 1-year low of $1.86 and a 1-year high of $17.20. The stock’s 50-day moving average is $2.73 and its 200 day moving average is $2.94. The company has a market cap of $27.57 million, a P/E ratio of -0.82 and a beta of 2.11.

Firefly Neuroscience (NASDAQ:AIFF) last issued its quarterly earnings data on Wednesday, August 13th. The company reported ($0.14) earnings per share for the quarter. Firefly Neuroscience had a negative net margin of 5,335.75% and a negative return on equity of 464.02%.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Institutional Investors Weigh In On Firefly Neuroscience

An institutional investor recently raised its position in Firefly Neuroscience stock. Geode Capital Management LLC grew its holdings in Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 120,604 shares of the company’s stock after acquiring an additional 58,067 shares during the quarter. Geode Capital Management LLC owned 0.94% of Firefly Neuroscience worth $341,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.